Sheppard, Richard J.
Watson, Oliver J. http://orcid.org/0000-0003-2374-0741
Pieciak, Rachel
Lungu, James
Kwenda, Geoffrey
Moyo, Crispin
Chanda, Stephen Longa http://orcid.org/0000-0002-4326-8571
Barnsley, Gregory http://orcid.org/0000-0001-7972-0737
Brazeau, Nicholas F.
Gerard-Ursin, Ines C. G.
Olivera Mesa, Daniela http://orcid.org/0000-0002-6190-2855
Whittaker, Charles http://orcid.org/0000-0002-5003-2575
Gregson, Simon
Okell, Lucy C. http://orcid.org/0000-0001-7202-6873
Ghani, Azra C. http://orcid.org/0000-0002-0007-4910
MacLeod, William B.
Del Fava, Emanuele http://orcid.org/0000-0001-7352-8525
Melegaro, Alessia http://orcid.org/0000-0003-2221-8898
Hines, Jonas Z.
Mulenga, Lloyd B.
Walker, Patrick G. T.
Mwananyanda, Lawrence
Gill, Christopher J.
Article History
Received: 13 January 2023
Accepted: 6 June 2023
First Online: 29 June 2023
Change Date: 12 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-44940-w
Competing interests
: S.G. declares shareholdings in pharmaceutical companies (AstraZeneca and GlaxoSmithklineBeecham). L.C.O. declares grant funding for other projects from Merck Ltd. The remaining authors declare no competing interests.